EIHSX Performance — Eaton Vance Worldwide Health Sciences Fund, Class I
Data updated: 2026-07-27
EIHSX returned −5.94% year to date and +5.97% over one year to May 2026. Annualised returns are +4.54% over 3 years and +3.56% over 5 years. The fund trailed its Global Health Care Equity category average: $100 invested three years ago grew to $114, against $126 for the category, and to $106 over one year, against $120. Volatility over the past three years was 13.23% a year. In the 12 months to May 2026 the fund lost a net $93.1M, and assets reached $757.90M.
EIHSX Growth of $100
What $100 invested in Eaton Vance Worldwide Health Sciences Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Health Care Equity category average over the same months.
| Period | EIHSX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $106 | $120 |
| 3 years (Jun 2023 – May 2026) | $114 | $126 |
| 5 years (Jun 2021 – May 2026) | $119 | $103 |
| Since data start (Sep 2019 – May 2026) | $163 | $154 |
EIHSX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −5.94% |
| 1 year | +5.97% |
| 3 years (annualised) | +4.54% |
| 5 years (annualised) | +3.56% |
EIHSX Annual Returns
Calendar-year total returns of Eaton Vance Worldwide Health Sciences Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | −5.94% |
| 2025 | +10.56% |
| 2024 | +3.74% |
| 2023 | +5.98% |
| 2022 | −9.12% |
| 2021 | +22.39% |
| 2020 | +13.35% |
| 2019 (Sep–Dec) | +12.74% |
EIHSX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.4% | +1.5% | −7.6% | −0.9% | +0.9% | — | — | — | — | — | — | — |
| 2025 | +6.6% | +1.3% | −4.0% | −1.7% | −3.6% | +1.0% | −3.9% | +4.9% | −0.4% | +3.5% | +7.7% | −0.4% |
| 2024 | +2.6% | +3.3% | +1.9% | −4.0% | +3.6% | +2.6% | +3.3% | +5.4% | −2.7% | −4.7% | −0.6% | −6.2% |
| 2023 | −0.5% | −3.8% | +4.1% | +3.6% | −3.1% | +3.0% | +1.3% | −0.6% | −3.7% | −4.3% | +6.1% | +4.5% |
| 2022 | −8.9% | +0.5% | +5.5% | −5.2% | −0.6% | −1.7% | +3.3% | −7.7% | −4.3% | +7.3% | +5.4% | −1.6% |
| 2021 | −0.4% | −1.4% | +2.2% | +4.2% | +2.1% | +2.7% | +3.5% | +3.4% | −5.8% | +6.8% | −4.3% | +8.4% |
| 2020 | −1.6% | −6.5% | −3.3% | +11.2% | +3.8% | −1.1% | +3.7% | +2.7% | −1.5% | −4.6% | +7.3% | +3.8% |
| 2019 | — | — | — | — | — | — | — | — | −0.7% | +4.4% | +4.5% | +4.0% |
EIHSX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 13.23%
- 3-year Sharpe ratio: 0.00 (vs 4.5% risk-free rate)
- Best month: +7.67% (Nov 2025)
- Worst month: −7.61% (Mar 2026)
EIHSX Fund Flows
Monthly money in and out of Eaton Vance Worldwide Health Sciences Fund, from SEC Form N-PORT.
- 12-month net flow: −$93.1M
- 12-month gross sales (incl. reinvestments): $125.2M
- Sales ÷ redemptions: 0.57×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $8.8M | $19.6M | −$10.8M |
| Apr 2026 | $5.9M | $17.9M | −$12.0M |
| Mar 2026 | $11.3M | $21.1M | −$9.8M |
| Feb 2026 | $7.0M | $17.8M | −$10.8M |
| Jan 2026 | $7.1M | $18.0M | −$10.9M |
| Dec 2025 | $70.3M | $29.2M | $41.1M |
| Nov 2025 | $1.4M | $12.9M | −$11.5M |
| Oct 2025 | $2.3M | $16.8M | −$14.5M |
| Sep 2025 | $2.0M | $14.3M | −$12.3M |
| Aug 2025 | $2.1M | $18.1M | −$16.1M |
| Jul 2025 | $3.4M | $19.3M | −$15.9M |
| Jun 2025 | $3.6M | $13.3M | −$9.7M |
EIHSX Assets Under Management
Net assets of Eaton Vance Worldwide Health Sciences Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $757.90M |
| 2026-02-28 | $858.03M |
| 2025-11-30 | $885.22M |
| 2025-08-31 | $834.61M |
| 2025-05-31 | $861.68M |
| 2025-02-28 | $979.88M |
| 2024-11-30 | $1.01B |
| 2024-08-31 | $1.12B |
| 2024-05-31 | $1.02B |
| 2024-02-29 | $1.03B |
| 2023-11-30 | $953.53M |
| 2023-08-31 | $1.00B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.